AT&T and Thales Collaborate to Revolutionize IoT Deployments With New eSIM Solution
30.10.2025 13:00:00 CET | Business Wire | Press release
AT&T and Thales introduce a next generation eSIM solution, powered by the latest GSMA IoT specification (SGP.32), giving enterprises a consolidated platform to remotely and securely manage IoT subscriptions, while preserving device integrity on a highly secure and reliable network.Backed by Thales’ “secure by design” approach, this solution targets the highest level of cybersecurity for IoT devices and supports compliance with evolving global cybersecurity regulations.Optimized for large-scale IoT deployments, the new eSIM management platform simplifies operations, reduces costs, and delivers advanced automation beyond SGP.32 standards to support diverse industries and device types.
With over 5.8 billion IoT cellular connections expected globally by 2030 (GSMA Intelligence) — powering everything from smart meters to wearable health trackers — the need for secure, scalable, and easy-to-manage connectivity is greater than ever. AT&T, a leader in connectivity and IoT solutions, and Thales, a global leader in advanced Cyber & Digital technologies, announce the launch of a new eSIM solution designed to help businesses remotely activate and manage IoT devices. This eSIM solution, powered by Thales Adaptive Connect (TAC), becomes a key part of AT&T’s global IoT solution, AT&T Virtual Profile Management for IoT, and can support many industries worldwide including automotive, smart cities, healthcare and utilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030899315/en/

Source 123Ref
Compliant with the GSMA SGP.32 standard1, the new solution enables customers to ship connected devices anywhere in the world with one single, pre-integrated eSIM from Thales, then seamlessly activate the correct local connectivity profile remotely, eliminating the need for any physical access to it. This results in faster launches and simpler logistics for global IoT deployments. It also enables AT&T and its customers to easily manage connectivity policies, diagnostics, and subscription changes entirely over the air, through a single unified industry-certified interface.
This solution also adds advanced automation to simplify the remote eSIM management of large numbers of devices. It automates complex tasks—such as switching subscriptions or updating fleets rules—so enterprises can spend less time on logistics and operations, while bringing new products and services faster to market.
____________________ |
1 The GSMA SGP.32 standard the latest specification from the GSM Association for eSIM (embedded SIM) Remote SIM Provisioning (RSP), for the remote eSIM management of Internet of things (IoT) devices and other types of mobile device deployments. |
Thanks to these advanced features, Thales’ eSIM solution (TAC) gives companies the flexibility to localize within AT&T network partners or adjust devices’ subscriptions across large fleets without hardware changes, helping optimize costs, supply chains, coverage, and performance.
The service is now available for commercial use and supports customers worldwide.
“At AT&T, we deliver intelligent IoT solutions you can trust—highly secure, end-to-end, and built to scale,” saidCameron Coursey, VP of AT&T Connected Solutions. “Our state-of-the-art approach, paired with Thales’ solution, will help customers reduce friction and gain control of managing their own devices with reliable connectivity.”
“We are entering a new era for remote eSIM Provisioning, ready to power billions of IoT devices, and we are proud to collaborate with AT&T in delivering smarter and safer IoT connectivity around the world,” said Eva Rudin, EVP Mobile Connectivity Solutions at Thales. “With Thales Adaptive Connect, we’re ensuring that every connected device benefits from strong security, reliable service, and simplified management — from the first connection and throughout its lifetime.”
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies for the Defence, Aerospace, and Cyber & Digital sectors. Its portfolio of innovative products and services addresses several major challenges: sovereignty, security, sustainability and inclusion.
The Group invests more than €4 billion per year in Research & Development in key areas, particularly for critical environments, such as Artificial Intelligence, cybersecurity, quantum and cloud technologies.
Thales has more than 83,000 employees in 68 countries. In 2024, the Group generated sales of €20.6 billion.
About Thales in the U.S.
In the United States, Thales has conducted significant research and development, manufacturing, and service capabilities for more than 130 years. Today, Thales has 40 locations around the U.S., employing nearly 5,000 people. Working closely with customers and local partners, Thales is able to meet the most complex requirements for every operating environment.
About AT&T
We help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility. From the first phone call 140+ years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives. For more information about AT&T Inc. (NYSE:T), please visit us at about.att.com. Investors can learn more at investors.att.com.
PLEASE VISIT
Thales Group
Download HD photos
View source version on businesswire.com: https://www.businesswire.com/news/home/20251030899315/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
RevolKa Reimagines Antibody Engineering with "RevoAb®"1.4.2026 06:30:00 CEST | Press release
A Same-day Sequence Optimization Service to Elevate Antibody Expression Levels by RevolKa’s advanced AI Protein Engineering Engine RevolKa Ltd. (RevolKa), a venture-backed biotech company providing an advanced AI protein engineering technology platform, called aiProtein®, is pleased to announce the official global launch of RevoAb®, an innovative and quick online service for antibody sequence optimization to solve challenges in physicochemical properties, especially antibodyyields. RevoAb®:The Next-Gen AI Antibody Design Since December 2023, RevolKa has provided an antibody optimization services utilizing aiProtein®. The newly launched RevoAb® is a quick intuitive online antibody sequence optimization service that integrates RevolKa’s core technology—the "Refined Naturalness Framework Engineering". RevoAb® is designed to generate antibody framework sequences optimized for improved physicochemical properties, especially protein expression levels, without trade-off of affinity. This allo
Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying1.4.2026 03:00:00 CEST | Press release
Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its State of Beauty 2026 report, showing the global beauty market grew 10% year-on-year, with E-commerce expanding six times faster than in-store sales. The findings highlight a rapid shift to digital-first, AI-influenced commerce across key global markets. As consumer expectations evolve toward convenience, personalization, and seamless digital experiences, beauty brands are under increasing pressure to adapt. From AI-powered product discovery to social commerce and livestream shopping, the path to purchase is becoming more dynamic—requiring brands to move faster and engage consumers across an increasingly complex ecosystem. Key findings from the State of Beauty 2026 report: Global beauty sales grew 10% year-over-year, driven by strong digital acceleration E-commerce is growing 6x faster than in-store sales,
bet365 Partners with TestMu AI to Accelerate Global Release Velocity with Agentic AI Quality Engineering31.3.2026 19:01:00 CEST | Press release
Streamlines Hillside Technology testing across browsers and mobile devices while supporting rapid expansion into regulated markets. TestMu AI (Formerly LambdaTest), the world's first full-stack Agentic AI Quality Engineering platform, today announced that Hillside Technology Limited, the technology powerhouse behind global online gambling leader bet365, has adopted its platform to unify software testing and support hundreds of weekly production releases. The global online gaming industry is currently experiencing a massive shift, with the market projected to exceed $150 billion by 2030. As mobile gaming becomes the primary touchpoint for users, the technical complexity of delivering a seamless, low-latency experience has grown exponentially. For industry giants like bet365, the need to validate software across an infinite matrix of hardware, screen resolutions, and OS versions is a mission-critical requirement. This partnership ensures that, as gaming becomes more mobile-centric, bet36
IFF Secures First Heart Health Claim for Soy Protein in Australia and New Zealand31.3.2026 16:00:00 CEST | Press release
Regulatory milestone opens heart health growth opportunities for food and beverage manufacturers IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and health & biosciences announced today that a new heart health claim for isolated soy protein has been accepted by the Food Standards Australia New Zealand (FSANZ). The approval enables food and beverage manufacturers in Australia and New Zealand to link soy protein consumption with healthy blood cholesterol levels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330523416/en/ First heart health claim approved for soy protein in Australia and New Zealand. “For decades, IFF has invested in the science behind soy protein and its role in supporting cardiovascular health,” said Tony Andrew, vice president of protein solutions for IFF Food Ingredients. “This approved claim validates years of rigorous research and collaboration. With our deep expertise in ing
Sub-Q Bionics Closes $1.5M Pre-Seed Round to Advance Next-Generation Solution for Lymphedema Care31.3.2026 15:26:00 CEST | Press release
Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed funding round. The round includes investment from Mayo Clinic and Yeda, the technology transfer company of the Weizmann Institute of Science, as well as several private investors. The Israel Innovation Authority also provided matching funds. The funding will enable Sub-Q Bionics to continue to develop its novel bionic lymph node technology designed to transform how lymphedema is managed, based on scientific innovations from the Weizmann Institute and Shamir Medical Center. The system aims to provide a solution to manage fluid with a subcutaneous implant that will allow patients freedom of movement, automatic fluid management and reduction of symptoms such as pain and swelling. Lymphedema affects millions of patients worldwide, especially breast cancer survivors, and remains significantly under
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom